Sagimet Biosciences Inc.

Contributing Author

Recent Articles by Sagimet Biosciences Inc.

Jun-09	Sagimet Biosciences to Host Virtual KOL Event, "A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne" on June 16, 2025 SGMT GlobeNewswire
Jun-04	Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat for the Treatment of Moderate-to-Severe Acne from Partner Ascletis SGMT GlobeNewswire
May-22	Sagimet Biosciences to Host Virtual KOL Event, "Evaluating the Synergistic Potential of a Combination of Denifanstat and Resmetirom for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)" on May 29, 2025 SGMT GlobeNewswire
May-08	Sagimet Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates SGMT GlobeNewswire